Efficacy of Switching to DTG/3TC in Virologically-suppressed Adults Currently on B/F/TAF

NCT04585737 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

222

Enrollment

OTHER

Sponsor class

Conditions

HIV I Infection

Interventions

DRUG: Dolutegravir / Lamivudine Pill
DRUG: Bictegravir / Emtricitabine / Tenofovir Alafenamide Pill

Sponsor

Charlotte-Paige Rolle, MD

Collaborators

[object Object]